A Study of the Combination of Multiple Doses of RO5285119 With a Single Dose of Risperidone in Healthy Volunteers

Inclusion criteria

• Healthy male and female adults, 18 - 50 years of age inclusive Healthy status is defined by absence of evidence of any active or chronic disease following detailed medical and surgical history and a physical examination including vital signs, 12-lead ECG, hematology, blood chemistry, serology and urinalysis
• Body mass index (BMI) 18 to 30 kg/m2 inclusive
• Women have to be postmenopausal or surgically sterile
• Male subjects must use a barrier method of contraception for the duration of the study and for 3 months after last dosing

Exclusion criteria

• Suspicion of regular consumption of drug of abuse, or history of drug or alcohol abuse
• Positive for hepatitis B, hepatitis C or HIV infection
• History of clinically significant hypersensitivity or allergic reactions
• Disorders of the central nervous system, including psychiatric disorders, behavioural disturbances, cerebrovascular events, depression, bipolar disorder, migraine, Parkinson
• Regular smoker (>5 cigarettes, >3 pipe-fulls, >3 cigars per day)
• Administration of an investigational drug or device within 3 months prior to first dosing

• Hypersensitivity to risperidone or any of its excipients
• Any other known contraindications to risperidone as stated in the SmPC